Industry has responded positively to the United Kingdom government's new pharmaceutical payment system to incentivize development of new drugs to tackle AMR. / read more /
advertisement
Subscribe
Subscribers can enjoy each full issue of Pharm Tech Europe in print, or via Pharm Tech Europe apps.
AstraZeneca has revealed that the CHMP of the European Medicines Agency has given a positive opinion to adding a self-administration option for Fasenra (benralizumab). / read more /
Metabolic-disease biotech Amicus Therapeutics announced a manufacturing agreement with Catalent's Paragon Gene Therapy unit for gene therapy manufacturing. / read more /
Oncology drug discovery and development company, ADC Therapeutics, has closed its Series E financing expansion, in which it raised $103 million. / read more /
The Native Antigen Company has revealed its appointment of Biozol and Shanghai Bioleaf as its distributors in Germany, Switzerland, Austria, and China. / read more /
CatSci has received two accolades from Welsh organizations, demonstrating its contributions to the Welsh economy in the field of process R&D. / read more /
Will EMA's draft guideline clarify questions about the assessment of drug device combinations in relation to the EU medical devices regulation? / read more /
To rapidly achieve high-quality pharmaceutical manufacturing processes, industry must develop prospective, management-based approaches instead of retrospective performance-based measures. / read more /
This article discusses current methods of endotoxin testing, its importance to the industry, sustainability issues relating to the process, and best practices. / read more /
SMA MicroParticle ICS™
VAI is pleased to announce the addition of the SMA MicroParticle ICS line of non-viable particle counters that utilize the latest innovation in particle counting technology, to our contamination control portfolio. / Read more/
The editors explore novel technologies for the formulation, manufacture,
purification, and delivery of sterile small- and large-molecule drugs including single-use systems, facilities and equipment, contamination issues, and process analytics.
